Showing results (1421-1430 of 1,450) with videos related to
Sort By:
Pageof 145
Nature|April 30, 2014
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate heartsJames J H Chong, Xiulan Yang, Creighton W Don, et al.Nature Reviews. Cardiology|December 25, 2015
Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatmentLarissa Fabritz, Eduard Guasch, Charalambos Antoniades, et al.Nature Biotechnology|July 4, 2018
Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primatesYen-Wen Liu, Billy Chen, Xiulan Yang, et al.Cell Stem Cell|April 7, 2023
Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapySilvia Marchiano, Kenta Nakamura, Hans Reinecke, et al.Science (New York, N.Y.)|March 17, 2023
Decrypting drug actions and protein modifications by dose- and time-resolved proteomicsJana Zecha, Florian P Bayer, Svenja Wiechmann, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for cliniciansGeorgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.Der Nervenarzt|November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.JAMA Neurology|March 9, 2026
Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory DiseasesHannes Vietzen, Laura M Kühner, Sarah M Berger, et al.Pharmacopsychiatry|September 15, 2017
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.Neurology(R) Neuroimmunology & Neuroinflammation|September 15, 2025
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 PatientsTobias Baumgartner, Moritz Freyberg, Lucia Campetella, et al.Pageof 145